Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.41 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.41 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25530864 | 0.98 | MAPK1 (0.48) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL31663675 | 0.95 | MAPK1 (0.43) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL25416159 | 0.94 | MAPK1 (0.45) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL17367570 | 0.93 | GAA (0.47) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL25419620 | 0.91 | ALDH1A1 (0.46) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL25417070 | 0.91 | ALDH1A1 (0.46) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL25418208 | 0.91 | ALDH1A1 (0.46) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL25529677 | 0.91 | ALDH1A1 (0.46) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL25529674 | 0.91 | ALDH1A1 (0.46) | MAPK1MAPTLMNAALDH1A1PRKCA | |
| SCHEMBL25623384 | 0.91 | TLR2 (0.48) | MAPK1MAPTLMNAALDH1A1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4426270-B1 | LIPID NANOPARTICLES FOR OLIGONUCLEOTIDE DELIVERY | ZIPHIUS NV (BE) | 2025-07-23 | — | — | EP | claimed |
| US-20250236599-A1 | LIPID NANOPARTICLES FOR OLIGONUCLEOTIDE DELIVERY | ZIPHIUS NV (BE) | 2025-07-24 | — | — | US | disclosed |
| EP-4426270-B1 | LIPID NANOPARTICLES FOR OLIGONUCLEOTIDE DELIVERY | ZIPHIUS NV (BE) | 2025-07-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250236599-A1 | LIPID NANOPARTICLES FOR OLIGONUCLEOTIDE DELIVERY | MAPT, NPC1L1, SLC10A1 | MAPK1 1650/4885MAPT 1/4885LMNA 1214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.